What is the address of PHARMA VISION?

The registered office of PHARMA VISION is located at Weilandstraat 24 box 7, 1082 Sint-Agatha-Berchem.

Is PHARMA VISION still active?

Yes. According to the CBE (29 October 2026) PHARMA VISION is active, legal situation “Normale toestand”, started on 19 August 2005.

Is PHARMA VISION registered on Peppol?

Yes, PHARMA VISION is registered on the Peppol network with ID 0208:0875626918.

What is the enterprise number of PHARMA VISION?

The enterprise number of PHARMA VISION is BE0875626918.

When was PHARMA VISION founded?

PHARMA VISION was founded on 19 August 2005.

Who are the directors of PHARMA VISION?

According to the 2025 annual accounts, the directors of PHARMA VISION are: Frederic ROLLAND.

Is PHARMA VISION a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 19 August 2005; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMA VISION make in 2025?

PHARMA VISION posted a profit after taxes of € 61,409 in financial year 2025.

What is the revenue of PHARMA VISION?

As a small company, PHARMA VISION is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 114,928.

PHARMA VISION (Private Limited) - Sint-Agatha-Berchem

Q: What does PHARMA VISION do?

PHARMA VISION is registered with the CBE as active in: Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies. Private Limited, started on 19 August 2005, 1 establishment.

Dossier PHARMA VISION, printed on 29 October 2026 from databakkes.be/en/0875626918/pharma-vision. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMA VISION from Sint-Agatha-Berchem, company number BE0875626918, closed financial year 2025 with a result of € 61,409 after tax. For that financial year PHARMA VISION recorded a gross margin of € 114,928 and equity of € 117,198. Compared with financial year 2024, the result moved from € 134,352 to € 61,409. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 2, 2026.

What it is worth Growing

€ 117,198

▲ 110% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 61,409

▼ 54% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 103,044

▲ 121% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 104,798.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 2,861

▼ 42% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 71,261

▲ 7% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 14,198

▲ € 11,136 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 77,317

▲ 6% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 205,336 Gross margin 2022: € 205,336 First fiscal year in the series	€ 132,117 Gross margin 2023: € 132,117 ▼ 36% vs 2022 (€ 205,336) Unfavourable step	€ 223,619 Gross margin 2024: € 223,619 ▲ 69% vs 2023 (€ 132,117) Favourable step	€ 114,928 Gross margin 2025: € 114,928 ▼ 49% vs 2024 (€ 223,619) Unfavourable step	▼ 49%
Profit after taxes	€ 131,359 Profit after taxes 2022: € 131,359 First fiscal year in the series	€ 83,219 Profit after taxes 2023: € 83,219 ▼ 37% vs 2022 (€ 131,359) Unfavourable step	€ 134,352 Profit after taxes 2024: € 134,352 ▲ 61% vs 2023 (€ 83,219) Favourable step	€ 61,409 Profit after taxes 2025: € 61,409 ▼ 54% vs 2024 (€ 134,352) Unfavourable step	▼ 54%
Equity	€ 94,925 Equity 2022: € 94,925 First fiscal year in the series	€ 93,458 Equity 2023: € 93,458 ▼ 2% vs 2022 (€ 94,925) Unfavourable step	€ 55,788 Equity 2024: € 55,788 ▼ 40% vs 2023 (€ 93,458) Unfavourable step	€ 117,198 Equity 2025: € 117,198 ▲ 110% vs 2024 (€ 55,788) Favourable step	▲ 110%
Total debts	€ 303,629 Total debts 2022: € 303,629 First fiscal year in the series	€ 238,786 Total debts 2023: € 238,786 ▼ 21% vs 2022 (€ 303,629) Favourable step	€ 285,275 Total debts 2024: € 285,275 ▲ 19% vs 2023 (€ 238,786) Unfavourable step	€ 171,561 Total debts 2025: € 171,561 ▼ 40% vs 2024 (€ 285,275) Favourable step	▼ 40%
Cash	€ 129,334 Cash 2022: € 129,334 First fiscal year in the series	€ 176,441 Cash 2023: € 176,441 ▲ 36% vs 2022 (€ 129,334) Favourable step	€ 46,532 Cash 2024: € 46,532 ▼ 74% vs 2023 (€ 176,441) Unfavourable step	€ 103,044 Cash 2025: € 103,044 ▲ 121% vs 2024 (€ 46,532) Favourable step	▲ 121%
Retained profit	€ 82,525 Retained profit 2022: € 82,525 First fiscal year in the series	€ 81,058 Retained profit 2023: € 81,058 ▼ 2% vs 2022 (€ 82,525) Unfavourable step	€ 43,388 Retained profit 2024: € 43,388 ▼ 46% vs 2023 (€ 81,058) Unfavourable step	€ 104,798 Retained profit 2025: € 104,798 ▲ 142% vs 2024 (€ 43,388) Favourable step	▲ 142%
Dividend	€ 131,359 Dividend 2022: € 131,359 First fiscal year in the series	€ 84,686 Dividend 2023: € 84,686 ▼ 36% vs 2022 (€ 131,359) Unchanged	€ 172,022 Dividend 2024: € 172,022 ▲ 103% vs 2023 (€ 84,686) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 172,022) Unchanged	▼ 100%
Bank debt	€ 68,664 Bank debt 2022: € 68,664 First fiscal year in the series	€ 61,959 Bank debt 2023: € 61,959 ▼ 10% vs 2022 (€ 68,664) Favourable step	€ 66,742 Bank debt 2024: € 66,742 ▲ 8% vs 2023 (€ 61,959) Unfavourable step	€ 71,261 Bank debt 2025: € 71,261 ▲ 7% vs 2024 (€ 66,742) Unfavourable step	▲ 7%
Balance sheet total	€ 398,554 Balance sheet total 2022: € 398,554 First fiscal year in the series	€ 332,244 Balance sheet total 2023: € 332,244 ▼ 17% vs 2022 (€ 398,554) Unchanged	€ 341,063 Balance sheet total 2024: € 341,063 ▲ 3% vs 2023 (€ 332,244) Unchanged	€ 288,758 Balance sheet total 2025: € 288,758 ▼ 15% vs 2024 (€ 341,063) Unchanged	▼ 15%

Key figures of PHARMA VISION, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMA VISION?

What happened at PHARMA VISION in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 2, 2026 New annual accounts for financial year 2025: profit of € 61,409 (▼ 54% vs 2024). filed late Source: NBB ↗
Aug 19, 2005 Start of the company according to the CBE. KBO
Aug 16, 2005 New establishment in Sint-Jans-Molenbeek. KBO
2005 Frederic ROLLAND became a director. NBB

In short

From € 131,359 profit in 2022 to € 61,409 profit in 2025.

Paid € 180,075 in corporate taxes since 2022.

Best year ever: 2024, with € 134,352 profit.

Paid out € 388,067 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Frederic ROLLAND

PHARMA VISION

Behind PHARMA VISION is Frederic ROLLAND.

Directors

According to the 2025 annual accounts

Frederic ROLLAND

Director

since 2005

Establishments

Establishment units

Physical locations of this company

Registered office

Weilandstraat 24 box 7

1082 Sint-Agatha-Berchem

2.148.848.621

Zaadstraat 73 box 13

1080 Sint-Jans-Molenbeek

Active since 16 August 2005

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 7 companies are registered at this address.

All companies at this address →

LOGIGOLD

€ -60,101 gross margin · 2025

KEYSER SOZE

€ -6,286 gross margin · 2025

BUGOOD FOOD

€ -1,391 gross margin · 2025

RBO CONSULTING

€ 75,220 revenue · 2022

Zicoteam-RCTA en abregé RCTA

+2 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0875.626.918

VAT number

BE 0875.626.918

Registered office

Weilandstraat 24 bus 7, 1082 Sint-Agatha-Berchem

Names & denominations

PHARMA VISION

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

19 August 2005

Peppol

Active · Active since 22 Dec 2025

Activities · NACE

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsvoering en beheer

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMA VISION

Financials

What happened to PHARMA VISION?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions